Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $66,461.

  • Cumberland Pharmaceuticals' Capital Expenditures rose 54.68% to $23,788 in Q3 2025 from the same period last year, while for Sep 2025 it was $100,187, marking a year-over-year decrease of 11.22%. This contributed to the annual value of $66,461 for FY2024, which is 76.37% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Capital Expenditures stood at $66,461 for FY2024, which was down 76.37% from $281,268 recorded in FY2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Capital Expenditures peaked at $281,268 during FY2023, and registered a low of $66,461 during FY2024.
  • Moreover, its 3-year median value for Capital Expenditures was $102,148 (2022), whereas its average is $149,959.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Capital Expenditures skyrocketed by 175.35% in 2023 and then plummeted by 76.37% in 2024.
  • Over the past 5 years, Cumberland Pharmaceuticals' Capital Expenditures (Yearly) stood at $140,817 in 2020, then decreased by 26.48% to $103,532 in 2021, then fell by 1.34% to $102,148 in 2022, then soared by 175.35% to $281,268 in 2023, then plummeted by 76.37% to $66,461 in 2024.